Elevation Wealth Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.1K Buy
118
+102
+638% +$22.3K 0.01% 595
2026
Q2
$3.12K Buy
16
+7
+78% +$1.45K ﹤0.01% 1118
2026
Q1
$2.02K Buy
+9
New +$2.24K ﹤0.01% 908
2025
Q4
– Sell
-16
Closed -$4.38K – 1013
2025
Q3
$4.38K Buy
+16
New +$4.37K ﹤0.01% 504

Other funds holding RMD

Elevation Wealth Partners's RMD Position: Q3 2026 in Review

Elevation Wealth Partners increased its ResMed (RMD) stake by 638% in Q3 2026, buying an estimated $22.3K and bringing the position to 118 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #595.

Elevation Wealth Partners first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. 231 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Elevation Wealth Partners held 118 shares of ResMed worth $26.1K as of Q3 2026.
  • Elevation Wealth Partners bought 102 ResMed shares in Q3 2026, an estimated $22.3K.
  • ResMed made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #595 holding.
  • Elevation Wealth Partners first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • 231 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.